Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
15th National Conference of the IAOMFP, Chennai, 2006
Abstract
Abstracts from current literature
Acne in India: Guidelines for management - IAA Consensus Document
Addendum
Announcement
Art & Psychiatry
Article
Articles
Association Activities
Association Notes
Award Article
Book Review
Brief Report
Case Analysis
Case Letter
Case Letters
Case Notes
Case Report
Case Reports
Clinical and Laboratory Investigations
Clinical Article
Clinical Studies
Clinical Study
Commentary
Conference Oration
Conference Summary
Continuing Medical Education
Correspondence
Corrigendum
Cosmetic Dermatology
Cosmetology
Current Best Evidence
Current View
Derma Quest
Dermato Surgery
Dermatopathology
Dermatosurgery Specials
Dispensing Pearl
Do you know?
Drug Dialogues
e-IJDVL
Editor Speaks
Editorial
Editorial Remarks
Editorial Report
Editorial Report - 2007
Editorial report for 2004-2005
Errata
Erratum
Focus
Fourth All India Conference Programme
From Our Book Shelf
From the Desk of Chief Editor
General
Get Set for Net
Get set for the net
Guest Article
Guest Editorial
History
How I Manage?
IADVL Announcement
IADVL Announcements
IJDVL Awards
IJDVL AWARDS 2015
IJDVL Awards 2018
IJDVL Awards 2019
IJDVL Awards 2020
IJDVL International Awards 2018
Images in Clinical Practice
In Memorium
Inaugural Address
Index
Knowledge From World Contemporaries
Leprosy Section
Letter in Response to Previous Publication
Letter to Editor
Letter to the Editor
Letter to the Editor - Case Letter
Letter to the Editor - Letter in Response to Published Article
LETTER TO THE EDITOR - LETTERS IN RESPONSE TO PUBLISHED ARTICLES
Letter to the Editor - Observation Letter
Letter to the Editor - Study Letter
Letter to the Editor - Therapy Letter
Letter to the Editor: Articles in Response to Previously Published Articles
Letters to the Editor
Letters to the Editor - Letter in Response to Previously Published Articles
Letters to the Editor: Case Letters
Letters to the Editor: Letters in Response to Previously Published Articles
Medicolegal Window
Messages
Miscellaneous Letter
Musings
Net Case
Net case report
Net Image
Net Letter
Net Quiz
Net Study
New Preparations
News
News & Views
Obervation Letter
Obituary
Observation Letter
Observation Letters
Oration
Original Article
ORIGINAL CONTRIBUTION
Original Contributions
Pattern of Skin Diseases
Pearls
Pediatric Dermatology
Pediatric Rounds
Perspective
Presedential Address
Presidential Address
Presidents Remarks
Quiz
Recommendations
Regret
Report
Report of chief editor
Report of Hon : Treasurer IADVL
Report of Hon. General Secretary IADVL
Research Methdology
Research Methodology
Resident page
Resident's Page
Resident’s Page
Residents' Corner
Residents' Corner
Residents' Page
Retraction
Review
Review Article
Review Articles
Revision Corner
Self Assessment Programme
SEMINAR
Seminar: Chronic Arsenicosis in India
Seminar: HIV Infection
Short Communication
Short Communications
Short Report
Special Article
Specialty Interface
Studies
Study Letter
Supplement-Photoprotection
Supplement-Psoriasis
Symposium - Contact Dermatitis
Symposium - Lasers
Symposium - Pediatric Dermatoses
Symposium - Psoriasis
Symposium - Vesicobullous Disorders
SYMPOSIUM - VITILIGO
Symposium Aesthetic Surgery
Symposium Dermatopathology
Symposium-Hair Disorders
Symposium-Nails Part I
Symposium-Nails-Part II
Tables
Technology
Therapeutic Guidelines
Therapeutic Guidelines - IADVL
Therapeutics
Therapy
Therapy Letter
View Point
Viewpoint
What’s new in Dermatology
View/Download PDF
Letter to the Editor
2009:75:5;522-523
doi: 10.4103/0378-6323.55410
PMID: 19736444

Erythroderma: Clinical and laboratory follow up of 66 Mexican patients

Paula Torres-Camacho, Andres Tirado-Sanchez, Rosa Maria Ponce-Olivera
 Service of Dermatology, Hospital General de Mexico, O.D, Mexico

Correspondence Address:
Andres Tirado-Sanchez
Servicio de Dermatologa, Hospital General de Mexico, Dr. Balmis 148, Col. Doctores, Deleg. Cuauhtemoc, C.P. 06720, Mexico, D.F
Mexico
How to cite this article:
Torres-Camacho P, Tirado-Sanchez A, Ponce-Olivera RM. Erythroderma: Clinical and laboratory follow up of 66 Mexican patients. Indian J Dermatol Venereol Leprol 2009;75:522-523
Copyright: (C)2009 Indian Journal of Dermatology, Venereology, and Leprology

Sir,

Erythroderma, first described by Hebra in 1868, is an inflammatory disorder characterized by erythema and scaling involving more than 90% of the body surface. It results from a previous skin disease (psoriasis, atopic dermatitis), drugs, underlying neoplasm; or idiopathic, with an acute or insidious onset, and prognosis frequently related to the cause, time of evolution, onset, associated diseases, and laboratory findings. [1]

We studied records of 66 patients with erythroderma, admitted to the Department of Dermatology, Hospital General de Mexico, between 1996 and 2007. Data collected from the records comprised of onset of erythroderma, time of evolution, symptoms, associated disorders, previous skin disease, drug intake, aggravating factors, and laboratory parameters (hemoglobin, total leukocyte count, erythrocyte sedimentation rate [ESR], serum proteins, creatinine, electrolytes, lactate dehydrogenase [LDH], blood glucose, liver function test, urine examination, and chest x-ray). Skin biopsies were performed in all cases; lymph node biopsy, computerized axial scan, and determination of b2 microglobulin levels were undertaken when indicated. All records selected fulfilled inclusion criteria. The mean age at onset was 44 years (range, 15-84 years). The sample consisted of 18 female and 44 male patients. In our study, erythroderma commonly showed a gradual onset, frequently related to previous dermatosis (time of evolution, 6.47 ± 3.7 months). Itching and chills were the most common symptoms in 100% and 75% of the patients respectively. The most common causes of erythroderma were a) psoriasis (46%) classified as a previous disease, b) carbamazepine for drug-related erythroderma (69%), and c) cutaneous T-cell lymphoma for underlying neoplasm. The most important laboratory results were hypoalbuminemia (75%), eosinophilia (35%), and elevated ESR (30%). High levels of LDH were often related to an underlying neoplasm. We also performed a correlation study to show a possible association of eosinophilia and high levels of LDH with paraneoplastic erythroderma (PE) and found that these parameters are frequently associated with this type of erythroderma (497.75 ± 264.64 vs. 99.55 ± 31.46 IU/L, P ≤ 0.05). There were also differences between levels of blood eosinophils in patients with and without PE (1.55 ± 0.826 vs. 0.829 ± 0.179 K/mm 3 , P ≤ 0.05).

Since we did not find a positive association between levels of LDH and eosinophils in patients who died during hospitalization compared with those who lived, independently of the underlying cause, these parameters seem not to be prognostic factors, but are important in association with malignant neoplasm. In patients with erythroderma related to malignancy, LDH and eosinophils levels were higher than those found in patients with erythroderma secondary to other causes. Buechner and Winkelmann [2] recognized that a high level of tissue eosinophils is a bad prognostic factor in erythroderma, because there is a greater probability of it being associated with malignancy, mainly T-cell lymphoma. Similar findings on high serum levels of LDH were arrived at by Vonderheid et al . [3],[4]

Nail findings were recorded in all patients, onychodystrophy and Beau´s lines being the most frequent manifestations, probably due to the large number of cases associated with psoriasis. Skin biopsy is a helpful tool, but it always needs to be performed at more than one site to achieve diagnostic accuracy, especially in patients with gradual onset of erythroderma. Psoriasis was the most common underlying cause of erythroderma, in accordance with previous studies. [1],[4]

References
1.
Pal S, Haroon TS. Erythroderma: a clinico-ethiologic study of 90 cases. Int J Dermatol 1998;37:104-7.
[Google Scholar]
2.
Buechner SA, Winkelmann RK. Sezary syndrome. A clinicopathologic study of 39 cases. Arch Dermatol 1983;119:979-86.
[Google Scholar]
3.
Vonderheid EC, Pena J, Nowell P. Sezary cell counts in erythrodermic cutaneous T-cell lymphoma: Implications for prognosis and staging. Leuk Lymphoma 2006;47:1841-56.
[Google Scholar]
4.
Hasan T, Jansen CT. Erythroderma: A follow up of 50 cases. J Am Acad Dermatol 1983; 8: 836-40.
[Google Scholar]

Fulltext Views
83

PDF downloads
61
Show Sections